CLINICAL_TRIALS
research
· 2006-08-01
Clinical Trial Update: Guanfacine to Treat Borderline Personality Disorder [NA]
Summary
This entry reports a clinical trial investigating guanfacine for Borderline Personality Disorder, conducted by Icahn School of Medicine at Mount Sinai; the curr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Borderline Personality Disorder | NA | Status: UNKNOWN